
Pediatric Gastroenterologist

No OPD information available
Biliary Atresia
Cholangitis
Cirrhosis
Crohn's Disease
Cystic Fibrosis
Sclerosing Cholangitis
Viral Gastroenteritis
Autoimmune Hepatitis
Childhood Iron Deficiency Anemia
Cholestasis
Colitis
Colonoscopy
Gastroesophageal Reflux Disease (GERD)
Gastroesophageal Reflux in Infants
Gastrostomy
Hemolytic Transfusion Reaction
Hemorrhagic Proctocolitis
Hepatitis
Liver Failure
Liver Transplant
Portal Hypertension
Swallowing Difficulty
Tyrosinemia Type 1
Ulcerative Colitis
Peter J. Lewindon is a male doctor who helps kids with different tummy troubles like Biliary Atresia, Crohn's Disease, and Liver Transplants. He also takes care of issues like swallowing problems and anemia in children.
Dr. Lewindon is very good at what he does. He uses special skills and treatments to help his patients feel better. Kids and their families trust him because he talks to them in a kind and clear way. He listens to their worries and explains things in a simple manner.
Dr. Lewindon always learns new things in medicine to give the best care to his patients. He reads the latest research and goes to classes to stay updated. This helps him find better ways to treat kids with tummy problems.
Dr. Lewindon works well with other doctors and nurses. He shares ideas with them to help his patients even more. He is a team player who cares about working together to help kids get better.
Because of Dr. Lewindon's hard work, many kids have gotten better. His treatments have made a big difference in their lives. He also writes about his work in medical journals to share his knowledge with other doctors.
One of Dr. Lewindon's important studies is about using antibiotics to help kids with severe tummy issues. He is also doing a study on a new treatment for children with a type of tummy problem called ulcerative colitis.
In simple words, Dr. Peter J. Lewindon is a caring doctor who helps kids with tummy problems feel better. He learns new things, works well with others, and makes a positive impact on his patients' lives.
Enrollment Status: Active not recruiting
Published: September 20, 2024
Intervention Type: Drug
Study Drug: Vedolizumab
Study Phase: Phase 3
